Purpose: In the United States, it is estimated that 6.5 million people over the age of 40 have peripheral arterial disease (PAD). Radiologists examine computed tomography angiography (CTA...
Purpose: Gold standard treatment for occlusive lesions of the common femoral artery (CFA) used to be endarterectomy. In recent years, interest for endovascular treatment of the CFA has be...
Purpose: Chronic limb-threatening ischemia has associated morbidity, mortality, and impact on quality of life. This endovascular case had a high-complexity target path anatomy with retrog...
Purpose: We report the 24-month outcomes of the PROMISE I early US feasibility study (EFS) after treatment of no-option chronic limb-threatening ischemia (CLTI) with Transcatheter Arteria...
Purpose: The purpose of this study was analysis of clinical characteristics and results of surgical revascularization in patients with acute limb ischemia (ALI) and COVID-19, compared wit...
Purpose: Acute limb ischemia (ALI) occurs with an abrupt interruption of blood flow to the extremity and a sudden decrease in limb perfusion, threatening the limb viability. The incidenc...
Purpose: The investigators of this study provide an analysis of 15 patients treated with an autologous patch consisting of fibrin, leukocytes, and platelets. These patients have failed co...
Purpose: Critical limb ischemia (CLI) affects approximately 1 to 2 million people in the United States. One-year mortality after CLI diagnosis and amputation is 40%.
Purpose: Accessing stenosed lower-limb vasculature in peripheral arterial disease (PAD) and critical limb ischemia (CLI) patients requires low-profile catheters with long working lengths ...
Driven by a team of multidisciplinary course directors, AMP provides an unrivaled experience for endovascular and vascular specialists to gain knowledge on the latest advances in revascularization and explore groundbreaking techniques that will improve the future for CLI patients. More about AMP